BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29328409)

  • 21. Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3.
    Xia QY; Wang XT; Zhan XM; Tan X; Chen H; Liu Y; Shi SS; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
    Am J Surg Pathol; 2017 May; 41(5):663-676. PubMed ID: 28288037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG.
    Pu Y; Dong Z; Xia Y; Zhang M; Song J; Han J; Liu H
    Biomed Pharmacother; 2019 Oct; 118():109382. PubMed ID: 31545257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non‑coding RNA PLK1S1 was associated with renal cell carcinoma progression by interacting with microRNA‑653 and altering C‑X‑C chemokine receptor 5 expression.
    Li W; Yang D; Zhang Y; Zhao S; Li D; Liu M
    Oncol Rep; 2020 Nov; 44(5):1985-1996. PubMed ID: 33000253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological study of 5 cases of renal cell carcinoma with t(6;11)(p21;q12).
    Kuroda N; Yorita K; Sasaki N; Ishihara A; Matsuura K; Daa T; Mori S; Sasaki A; Mikami S; Shigematsu K; Nagashima Y
    Pol J Pathol; 2017; 68(1):66-72. PubMed ID: 28547982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion.
    Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q
    Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.
    Liu Y; Cheng G; Huang Z; Bao L; Liu J; Wang C; Xiong Z; Zhou L; Xu T; Liu D; Yang H; Chen K; Zhang X
    Cell Death Dis; 2020 Jul; 11(7):515. PubMed ID: 32641718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of renal carcinoma with t(6;11)(p21;q12) with focus on clinical and pathobiological aspects.
    Kuroda N; Tanaka A; Sasaki N; Ishihara A; Matsuura K; Moriyama M; Nagashima Y; Inoue K; Petersson F; Martignoni G; Michal M; Hes O
    Histol Histopathol; 2013 Jun; 28(6):685-90. PubMed ID: 23426439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal translocation carcinoma with expression of TFEB: presentation of a case with distinctive histological and immunohistochemical features.
    Suárez-Vilela D; Izquierdo-García F; Méndez-Álvarez JR; Miguélez-García E; Domínguez-Iglesias F
    Int J Surg Pathol; 2011 Aug; 19(4):506-9. PubMed ID: 19687027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal Cell Carcinoma Associated with t (6;11) Translocation/TFEB Gene Fusion: A Case Report and Review of Literature.
    Wang Y; Xu G; Yang H; Zhou X; Wen H
    Clin Genitourin Cancer; 2023 Apr; 21(2):309-313. PubMed ID: 36153295
    [No Abstract]   [Full Text] [Related]  

  • 30. MiT family translocation renal cell carcinoma.
    Argani P
    Semin Diagn Pathol; 2015 Mar; 32(2):103-13. PubMed ID: 25758327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.
    Kauffman EC; Ricketts CJ; Rais-Bahrami S; Yang Y; Merino MJ; Bottaro DP; Srinivasan R; Linehan WM
    Nat Rev Urol; 2014 Aug; 11(8):465-75. PubMed ID: 25048860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas.
    Medendorp K; van Groningen JJ; Schepens M; Vreede L; Thijssen J; Schoenmakers EF; van den Hurk WH; Geurts van Kessel A; Kuiper RP
    Cytogenet Genome Res; 2007; 118(2-4):157-65. PubMed ID: 18000366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
    Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
    Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.
    Koie T; Yoneyama T; Hashimoto Y; Kamimura N; Kusumi T; Kijima H; Ohyama C
    Int J Urol; 2009 Mar; 16(3):333-5. PubMed ID: 19298350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translocational renal cell carcinoma (t(6;11)(p21;q12) with transcription factor EB (TFEB) amplification and an integrated precision approach: a case report.
    Lilleby W; Vlatkovic L; Meza-Zepeda LA; Revheim ME; Hovig E
    J Med Case Rep; 2015 Dec; 9():281. PubMed ID: 26654961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.
    Xu Y; Rao Q; Xia Q; Shi S; Shi Q; Ma H; Lu Z; Chen H; Zhou X
    Int J Clin Exp Pathol; 2015; 8(3):2690-9. PubMed ID: 26045774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
    Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
    Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
    Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature: Evidence for a specific entity with poor outcome.
    Mendel L; Ambrosetti D; Bodokh Y; Ngo-Mai M; Durand M; Simbsler-Michel C; Delhorbe M; Amiel J; Pedeutour F
    Genes Chromosomes Cancer; 2018 Mar; 57(3):99-113. PubMed ID: 29127730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [TFEB-amplified renal cell carcinoma. A case report and review of the literature].
    Mayoral Guisado C; Gómez Durán Á; Agustín Benítez López D; Toro Zambrano W; Rubio Fernández A; Moreno Ontalba A; Díaz Delgado M
    Rev Esp Patol; 2018; 51(4):248-252. PubMed ID: 30269777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.